NCT03782688View on ClinicalTrials.gov

Precise Percutaneous Coronary Intervention Plan (P3) Study

CompletedOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

December 18, 2020

Study Completion Date

December 18, 2021

Conditions
Stable Coronary Artery Disease
Interventions
DIAGNOSTIC_TEST

FFRCT planner

Non-invasive post-PCI fractional flow reserve prediction

Trial Locations (1)

9300

OLV-Aalst, Aalst

All Listed Sponsors
lead

Onze Lieve Vrouw Hospital

OTHER

NCT03782688 - Precise Percutaneous Coronary Intervention Plan (P3) Study | Biotech Hunter | Biotech Hunter